b'I call this new wave of minor cannabi-noids Cannabis 3.0. The cannabis spaceWHAT ARE CBG AND CBD?really is being revolutionized and giving people a host of new therapeutic options,Cannabigerol (CBG) is a non-psychoactive cannabinoid that could possibly have Ghossein says. I get so many emails frombenefits in treating glaucoma, inflammatory bowel disease, and as an appetite stimulant.people excited to have a new option in CBG, and that excites our whole team. Cannabidiol (CBD) is a non-narcotic and may hold promise in treating anxiety, insomnia Cannabis Orchards has held a Healthand chronic pain. Canada plant breeding industrial hemp license since 2018. The license includes the cultivation, import, export, sale and production of hemp seed and flower, as well as the cultivation of unapproved cultivars for the purposes of registration, research and field testing.The company, which specializes in indoor feminized seed production, holdsTHE CANNABIS SPACE REALLY IS BEING REVOLUTIONIZED AND GIVING the exclusive rights to Panakeia for pro-duction and sale of seed, clone and plantPEOPLE A HOST OF NEW THERAPEUTIC OPTIONS.matter in Canada.Jamie GhosseinChallengesDespite the excitement in the cannabis community surrounding minor cannabi-noids like CBG, there are hurdles. The biggest one Cannabis Orchards faces at the moment, Ghossein says, is produc-ing enough feminized seed, cultivating enough acreage and making it availableduce as many seeds as possible and toOn behalf of the Canadian Hemp to as many people that need it as pos- get it to as many growers as possible,Trade Alliance (CHTA) Slaski coordinated sible.he says. But the main mission is reallygenerations of a robust set of analytical The company just purchased somebringing CBG to the hands of researchers,data showing that hemp grain and its land and is planning on building a dedi- clinicians and ultimately consumers whofractions including screenings and hulls cated feminized hemp seed productionwant access to it, he says.can be safely incorporated into livestock facility, what Ghossein says will be theHe expects the first CBG products tofeed. Currently the application package first of its kind. hit the market by the end of 2021 or earlyis being submitted to the CFIA seeking A big issue is preventing pollenin 2022 and expects another minor can- registration of eight hemp grain-based contamination between varieties whennabinoid to start making waves next yearproducts. youre working with more than one. Rightas well. The company also has a numberSlaski notes that when hemp grain is now, were only working with one vari- of in-house plant breeding projects forprocessed for human consumption, as ety, which makes it very simple. But wenew variety development. much as 40 per cent is discarded in the obviously want to increase the numberFor Jan Slaski of InnoTech Alberta, theform of shells, which he says could have of varieties that are available and thepotential goes beyond just cannabinoidgreat value in the livestock space. number of minor cannabinoids that wereproduction. He hopes hemp grain will offering. Meeting quality standards whensoon be utilized as livestock feed as well working with multiple varieties is the next which Health Canada currently does bridge we have to cross. not permit.The more feminized seed the com-pany can produce, the more acreage can be cultivated and the more CBG can be extracted for the market, he notes.For Health Canadas latest list of approved hemp cultivars, visit germination.ca/hemp-cultivarsA big goal for us is actually to pro-INTERNATIONAL EDITION 2022 GERMINATION.CA 7'